Blogs & News


Explore all that Huvepharma, Inc. has to offer!  Like us on Facebook and subscribe to our Youtube channel.

Huvepharma® Receives FDA Approval for Tilmovet® AC (tilmicosin phosphate)

Peachtree City, GA (February 9th, 2022) – Huvepharma® announces FDA approval for Tilmovet® AC (tilmicosin phosphate)

Huvepharma® announces Monovet® (monensin Type A medicated article) medicated feed combination approvals

The first FDA-approved generic monensin – available to U.S. beef, dairy, and goat producers as Monovet®90 (monensin Type A medicated article) from global animal health company Huvepharma®  – has now also received FDA approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.

FDA-approval granted to Huvepharma® for feed additive CycleGuard® 500 (melengestrol acetate Type A liquid...

PEACHTREE CITY, GA (June 24, 2020) — Huvepharma® has received FDA-approval for CycleGuard® 500 (melengestrol acetate).

Huvepharma helps customers succeed

"I've never had much luck selling the dead ones; you get the same price: nothing!", says Brad Haun, Fredonia Livestock owner, Fredonia, Kansas.

1 2 3 4 6
5-8 of 22 results